A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects
Clinical trial NCT01813448 · COMPLETED
Trial details
- NCT number
- NCT01813448
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2013-04-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.